Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice

Journal of Neural Transmission

Volumn 107, Issue 8-9, 2000, Pages 931-945

  Darmani, N A ^a   Pandya, D K ^a  

^a A T STILL UNIVERSITY   (United States)

Author keywords

994; AP 3; CNQX; CP 94; Glutamate; Head twitch; Scratching; Serotonin; SR 141716A; SR 46349B; Tachykinin

Indexed keywords

2 AMINO 3 PHOSPHONOPROPIONIC ACID; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 4 [3 [(2 DIMETHYLAMINOETHOXY)IMINO] 3 (2 FLUOROPHENYL) 1 PROPENYL]PHENOL HEMIFUMARATE; 5 (4 CHLOROPHENYL) 1 (2,4 DICHLOROPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; KAINIC ACID RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROKININ 1 RECEPTOR ANTAGONIST; SEROTONIN ANTAGONIST; TETRAHYDROCANNABINOL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HEAD TWITCH; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SCRATCHING; SEROTONINERGIC SYSTEM;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ALANINE; ANIMAL; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FLUOROBENZENES; GLUTAMIC ACID; HEAD MOVEMENTS; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED ICR; NEUROTRANSMITTERS; PHENOLS; PIPERIDINES; PSYCHOTROPIC DRUGS; PYRAZOLES; RECEPTORS, DRUG; SEROTONIN; SEROTONIN ANTAGONISTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TACHYKININS; TETRAHYDROCANNABINOL;

EID: 0033791204     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020070043     Document Type: Article

References (55)

1. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A
2. 9-tetrahydrocannabinol: Studies on precipitated and abrupt withdrawal
3. Anandamide, an endogenous cannabinoid, has very low physical dependence potential
4. Nonpeptide antagonists of neuropeptide receptors: Tools for research and therapy
5. Δ(9)-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain
6. Glutamate-dopamine interactions in the ventral striatum: Role in locomotor activity and responding with conditioned reinforcement
7. Serotonin and substance P co-exist in neurons of rat's central nervous system
8. Excitatory amino acid receptors in the vertebrate central nervous system
9. Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents
10. 9-tetrahydrocannabinol-induced responses and apparent agonist activity
11. 9-tetrahydrocannabinol
12. 2 receptor functions in the rat
13. 2 receptors?
14. 2-receptor interactions
15. Differential Dontogenesis of three DOI-induced behaviors in mice
16. The glutamate receptor ion channels
17. The maturational onset of the 5-HT mediated head twitch in mice
18. 1 receptors in the spinal cord changes substance P-induced behavior
19. Serotonin and gamma-aminobutyric acid turnover after injection into median raphe of substance P and D-Ala-Met-Enkephalin amide
20. Pharmacological identification of 5-HT subtypes using behavioral models
21. Identification of the central tachykin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats
22. Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment
23. 1 receptor
24. Effect of 6-cyano-2,3-dihydroxy-7-nitro-quinoxaline (CNQX) on dorsal root-, NMDA-, kainate- and quisqualate-mediated depolarization of rat motoneurons in vitro
25. The effect of 2-amino-3-phosphopropionic acid (AP-3) in the gerbil model of cerebral ischaemia
26. δ-9-tetrahydrocannabinol regulates substance P and enkephalin mRNAs levels in the caudate-putamen
27. Molecular aspects of cannabinoid receptors
28. Pharmacology of CP-99, 994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor
29. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: A role for the glycine site of the NMDA receptor, but not ampa receptors
30. 2 receptor subtypes in modulation behavior produced by excitatory aminoacid receptor agonists in mice
31. 9-tetrahydrocannabinol treatments
32. Kainic acid, a powerful neurotoxic analogue of glutamate
33. 2 receptors
34. Delta-9-tetrahydrocannabinol and brain biogenic amines
35. 2 and 5-HT(1C) receptors in the behavioral effects of the 5-HT agonist l(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI)
36. Differential ability of tachykinin NK-1 and NK-2 agonists to produce scratching and grooming behaviors in mice
37. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia
38. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine 2 receptor antagonist
39. SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor
40. Cannabinoid-precipitated withdrawal: A time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G-protein expression
41. 1 receptor antagonist CP-99, 994 in guinea-pigs
42. Differential effects of substance P analogs on neurokinin 1 receptor agonists in the mouse spinal cord
43. 1 antagonists and 5-HT(1A) agonists
44. 9-Tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture
45. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures
46. Endogenous and synthetic cannabinoids: Recent advances
47. The effect of repeated administration of delta-9-tetrahydrocannabinol on serotonin metabolism in the rat brain
48. Senktide, a selective neurokinin β-like agonist, elicits serotonin mediated behavior following intracisternal administration in the mouse
49. Effects of aging on tachykinin function in the basal ganglia
50. Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice
51. Pharmacology of systemically administered domoic acid in mice
52. 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist
53. CP-96, 345 which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse
54. Clonidine, but not ritanserin, suppresses kainic acid-induced automatisms in developing rats
55. The behavioral effects of systemically administered kainic acid: A pharmacological analysis